NIH-funded research Career grant

Improving stem cell transplants for treating blood disorders

Official title: Optimizing hematopoietic stem cell transplantation to treat non-malignant disease

Funded at Washington University · NIH-10984824 · Data updated 2026-11-12

This study is looking at new ways to make stem cell transplants safer and more effective for people with blood disorders like sickle cell disease, and it may involve patients trying out these improved methods.

Quick facts

Grant typeCareer grant
Study typeNIH-funded research
Funding institutionWashington University
NIH-funded
Lab location1 site (Saint Louis, United States)
Project startSeptember 17, 2024
Project endJune 30, 2029
Funding year2024
Award (this year)$169,156
NIH project number1K08HL168155-01A1
Project IDNIH-10984824 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals suffering from non-malignant hematologic diseases, particularly those with sickle cell disease.

Less likely to help

Patients with malignant blood disorders or those who do not have hematologic diseases may not benefit from this research.

What this research studies

This research focuses on enhancing hematopoietic stem cell transplantation (HSCT) techniques to treat non-malignant blood diseases, such as sickle cell disease. The approach involves optimizing the conditioning process, mobilizing stem cells effectively, and utilizing therapeutic gene editing to improve patient outcomes. By leveraging advanced immunological techniques and antibody-drug conjugates, the research aims to make HSCT safer and more effective for patients with these conditions. Patients may be involved in trials that assess the efficacy of these new methods.

Why it matters

Potential benefit: If successful, this research could lead to safer and more effective treatments for patients with non-malignant blood disorders.

How similar studies have gone: Previous research has shown promise in optimizing HSCT techniques, indicating that this approach has potential based on earlier successes.

Where this research is happening

  • Washington University
    Saint Louis, United States
    Active

Researchers

  • Principal investigator: Persaud, Stephen Phillip — Washington University
  • Study coordinator: Persaud, Stephen Phillip

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.